# Prevention of Coronary Aneurysms in Kawasaki Syndrome

> **NCT00000520** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Cardiovascular Diseases
- Coronary Aneurysm
- Heart Diseases
- Mucocutaneous Lymph Node Syndrome

## Interventions

- **DRUG:** immunoglobulins, intravenous
- **DRUG:** aspirin

## Key facts

- **NCT ID:** NCT00000520
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1985-07
- **Primary completion:** —
- **Final completion:** 1989-11
- **Target enrollment:** — (—)
- **Last updated:** 2013-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000520, "Prevention of Coronary Aneurysms in Kawasaki Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00000520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*